Association of KIF11 inhibitor 4bt in drug combination treatment regimen besides to cause a decrease in tumor volume it also caused a considerable reduction in intratumoral necrotic area (Figure 2F), even better than AC-T drug combination (Figure 2E), showing important antiproliferative activity in this tumor model. Here, KIF11 is linked to neoplasm.